ArticleJournal of experimental & clinical cancer research : CR2024

Ropivacaine as a novel AKT1 specific inhibitor regulates the stemness of breast cancer.

Lin Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.